EyePoint Pharmaceuticals, Inc. (EYPT) quarterly cash flow statement — complete operating, investing & financing history
| Cash from Operations | 0 | -65.05M | -59.35M | -62.59M | -53.12M | -35.85M | -39.03M | -20.18M | -31.17M | -23.11M | -15.2M | 57.02M |
| Operating CF Margin % | - | -10491.45% | -6144.31% | -1173.62% | -217.23% | -309.36% | -370.85% | -212.92% | -266.78% | -164.73% | -100.01% | 626.28% |
| Operating CF Growth % | 100% | -81.45% | -52.08% | -210.18% | -70.41% | -55.13% | -156.7% | -135.39% | -85.16% | -83.58% | -15.74% | 398.19% |
| Net Income | -84.83M | -67.61M | -59.73M | -59.43M | -45.2M | -41.4M | -29.36M | -30.83M | -29.28M | -14.1M | -12.61M | -22.92M |
| Depreciation & Amortization | 0 | 698K | 576K | 538K | 497K | 467K | 408K | 362K | 303K | 112K | 115K | 132K |
| Stock-Based Compensation | 0 | 6.75M | 6.43M | 6.88M | 7.82M | 7.9M | 7.45M | 8.7M | 12.7M | 3.59M | 3.63M | 1.79M |
| Deferred Taxes | 0 | 459K | -90K | 0 | 0 | 0 | 0 | 0 | 0 | 83K | 3.69M | 2.04M |
| Other Non-Cash Items | 84.83M | -1.03M | -861K | -1.29M | -1.73M | -1.72M | -28.55M | -1.69M | -575K | -522K | -3.72M | -51K |
| Working Capital Changes | 0 | -4.31M | -5.67M | -9.29M | -14.51M | -1.1M | 11.03M | 3.28M | -14.31M | -12.27M | -6.3M | 76.03M |
| Change in Receivables | 0 | -10.78M | -3.13M | -180K | 3.43M | 1.86M | -939K | 3.09M | -4.26M | -269K | 10.75M | -979K |
| Change in Inventory | 0 | 297K | 568K | -549K | 176K | 502K | 865K | 584K | -351K | 671K | -315K | -724K |
| Change in Payables | 0 | 6.23M | -3.06M | -3.47M | 4.97M | 8.13M | -6.04M | 5.07M | -1.43M | 728K | -2.89M | 5.95M |
| Cash from Investing | 0 | -74.67M | 55.38M | 48.34M | 39.52M | -95.96M | 16.2M | -160.4M | 20.81M | -47.15M | -1.72M | 13.47M |
| Capital Expenditures | 0 | -986K | -798K | -1.22M | -276K | -384K | -1.57M | -900K | -1.19M | -883K | -1.72M | -396K |
| CapEx % of Revenue | - | 159.03% | 82.61% | 22.88% | 1.13% | 3.31% | 14.96% | 9.5% | 10.22% | 6.29% | 11.31% | 4.35% |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 46.27M | 0 | -13.86M |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | -3.57M | 3.88M | 0 | 0 | 0 | 4.14M | 0 | 0 | -46.27M | 0 | 13.86M |
| Cash from Financing | 0 | 166.96M | 7.4M | 238K | -951K | 151.69M | 11.89M | 329K | 115K | 218.49M | 10.36M | -36.66M |
| Debt Issued (Net) | 0 | -27K | -27K | -16K | -35K | -32K | -73K | 0 | 0 | 1.31M | 0 | -35.3M |
| Equity Issued (Net) | 0 | 166.71M | 7.56M | 273K | 593K | 152.08M | -78K | 625K | 4.56M | 216.2M | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | -78K | 0 | 0 | 0 | 0 | 0 |
| Other Financing | 0 | 273K | -133K | -19K | -1.51M | -365K | 12.04M | -296K | -4.45M | 971K | 10.36M | -1.36M |
| Net Change in Cash | -24.11M | 27.24M | 3.43M | -14.02M | -14.55M | 19.87M | -10.94M | -180.24M | -10.25M | 148.23M | -6.56M | 33.83M |
| Free Cash Flow | 0 | -66.03M | -60.15M | -63.81M | -53.4M | -36.23M | -40.6M | -21.08M | -32.37M | -23.99M | -16.92M | 56.63M |
| FCF Margin % | - | -10650.48% | -6226.92% | -1196.49% | -218.36% | -312.68% | -385.8% | -222.41% | -277% | -171.03% | -111.33% | 621.93% |
| FCF Growth % | 100% | -82.25% | -48.15% | -202.73% | -64.98% | -51.02% | -139.91% | -137.22% | -86.88% | -82.13% | -18.07% | 392.78% |
| FCF per Share | - | -0.80 | -0.86 | -0.91 | -0.77 | -0.56 | -0.75 | -0.40 | -0.61 | -0.57 | -0.44 | 1.51 |
| FCF Conversion (FCF/Net Income) | - | 0.96x | 0.99x | 1.05x | 1.18x | 0.87x | 1.33x | 0.65x | 1.06x | 1.64x | 1.21x | -2.49x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |